Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ResMed Inc. (RMD : NYSE)
 
 • Company Description   
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.

Number of Employees: 7,970

 
 • Price / Volume Information   
Yesterday's Closing Price: $196.86 Daily Weekly Monthly
20 Day Moving Average: 632,251 shares
Shares Outstanding: 146.29 (millions)
Market Capitalization: $28,797.60 (millions)
Beta: 0.45
52 Week High: $301.34
52 Week Low: $189.40
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -15.95% -8.25%
12 Week -15.05% -8.19%
Year To Date -24.42% -10.48%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9001 SPECTRUM CENTER BLVD.
-
SAN DIEGO,CA 92123
USA
ph: 858-836-5000
fax: 858-836-5501
investorrelations@resmed.com http://www.resmed.com
 
 • General Corporate Information   
Officers
MichaelJ.Farrell - Chief executive officer and director
BrettA.Sandercock - Chief financial officer
PeterC.Farrell - Non-executive chairman
CarolJ.Burt - Director
Harjit Gill - Director

Peer Information
ResMed Inc. (BJCT)
ResMed Inc. (CADMQ)
ResMed Inc. (APNO)
ResMed Inc. (UPDC)
ResMed Inc. (IMTIQ)
ResMed Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 761152107
SIC: 3841
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 146.29
Most Recent Split Date: 8.00 (2.00:1)
Beta: 0.45
Market Capitalization: $28,797.60 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.85%
Current Fiscal Quarter EPS Consensus Estimate: $1.49 Indicated Annual Dividend: $1.68
Current Fiscal Year EPS Consensus Estimate: $5.73 Payout Ratio: 0.30
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: -0.07
Estmated Long-Term EPS Growth Rate: 15.73% Last Dividend Paid: 05/11/2022 - $0.42
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 34.33
Trailing 12 Months: 34.84
PEG Ratio: 2.18
Price Ratios
Price/Book: 8.78
Price/Cash Flow: 29.47
Price / Sales: 8.14
EPS Growth
vs. Year Ago Period: 1.54%
vs. Previous Quarter: -10.20%
Sales Growth
vs. Year Ago Period: 12.45%
vs. Previous Quarter: -3.40%
ROE
03/31/22 - 26.91
12/31/21 - 28.12
09/30/21 - 28.46
ROA
03/31/22 - 17.39
12/31/21 - 17.62
09/30/21 - 17.56
Current Ratio
03/31/22 - 2.55
12/31/21 - 2.49
09/30/21 - 2.54
Quick Ratio
03/31/22 - 1.56
12/31/21 - 1.54
09/30/21 - 1.73
Operating Margin
03/31/22 - 23.45
12/31/21 - 24.02
09/30/21 - 24.40
Net Margin
03/31/22 - 22.02
12/31/21 - 15.16
09/30/21 - 14.92
Pre-Tax Margin
03/31/22 - 27.17
12/31/21 - 27.68
09/30/21 - 27.67
Book Value
03/31/22 - 22.41
12/31/21 - 21.51
09/30/21 - 20.77
Inventory Turnover
03/31/22 - 2.79
12/31/21 - 2.93
09/30/21 - 3.00
Debt-to-Equity
03/31/22 - 0.20
12/31/21 - 0.21
09/30/21 - 0.26
Debt-to-Capital
03/31/22 - 16.94
12/31/21 - 17.51
09/30/21 - 20.78
 

Powered by Zacks Investment Research ©